Published:
Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit Against KV Pharmaceutical Company
Law Offices of Brian M. Felgoise, P.C.
announces that a class action has been commenced on behalf of shareholders
who acquired KV Pharmaceutical Company ("KV" or the "Company") Class A
Common Stock (NYSE: KV-A), Class B Common Stock (NYSE: KV-B) and 7%
cumulative convertible Preferred Stock (Symbol: KVPHP or CUSIP: 482740305)
securities between February 15, 2008 and November 12, 2008 (the "Class
Period").
The case is pending in the United States District Court for the Eastern
District of Missouri, against the company and certain key officers and
directors.
The action charges that defendants violated the federal securities laws by
issuing a series of materially false and misleading statements to the
market throughout the Class Period which statements had the effect of
artificially inflating the market price of the Company's securities.
No class has yet been certified in the above action. Until a class is
certified, you are not represented by counsel unless you retain one. If
you purchased the stock listed above during the class period, you have
certain rights. To be a member of the class you need not take any action
at this time, and you may retain counsel of your choice.
If you were a purchaser of a stock listed above during the period indicated
and want to discuss your legal rights, you may e-mail or call Law Offices
of Brian M. Felgoise, P.C. who will, without obligation or cost to you,
attempt to answer your questions. Law Offices of Brian M. Felgoise, P.C.
has extensive experience in the field of class action. You may contact
Brian M. Felgoise, Esquire at 261 Old York Road, Suite 423, Jenkintown,
Pennsylvania 19046, by calling (215) 886-1900 or by e-mail at
FelgoiseLaw@verizon.net.
Copyright © 2009, MarketWire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,ProfessionalServices:Legal, ,NYSE0001,NYSE0001,PA,PHILADELPHIA, PA
_ _
Breast Cancer News
Search News
Daily News
